This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Vesanoid (Tretinoin Oral) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (63)
Death (20)
Life Threatening Events (2)
Disability (1)
Reports by Reaction Type
Retinoic Acid Syndrome (8),
Acute Promyelocytic Leukaemia Differentiation Syndrome (6),
Pyrexia (6),
Myositis (6),
Haemorrhage (5),
Infection (5),
Death (5),
Benign Intracranial Hypertension (5),
Myocardial Infarction (5),
Renal Failure (5),
Embolism (5),
Neutropenia (5)
Below are a few examples of reports where side effects / adverse reactions may be related to Vesanoid (Tretinoin Oral). For a complete list or a specific selection of reports, please use the links above.
Possible Vesanoid side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-24
Patient: female
Reactions: Pregnancy
Drug(s) suspected as cause:
Clonazepam
Indication: Insomnia Related To Another Mental Condition
Vesanoid
Indication: Acne
Diazepam
Indication: Insomnia Related To Another Mental Condition
Isotretinoin
Indication: Acne
Possible Vesanoid side effects in male
Reported by a physician from Japan on 2012-08-09
Patient: male, weighing 60.0 kg (132.0 pounds)
Reactions: Retinoic Acid Syndrome, Pulmonary Congestion, Acute Promyelocytic Leukaemia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Vesanoid
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2008-10-09
End date: 2008-10-11
Vesanoid
Administration route: Oral
Start date: 2008-10-14
End date: 2008-11-10
Other drugs received by patient: Cytarabine; Fragmin; Heparin Calcium; Maxipime; Idamycin; Itraconazole
Possible Vesanoid side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-31
Patient:
Reactions: Cardiac Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Vesanoid
Vesanoid
Indication: Acute Promyelocytic Leukaemia
Daunorubicin HCL
Indication: Acute Promyelocytic Leukaemia
Cytarabine
Dosage: continous infusion for 7 days
Indication: Acute Promyelocytic Leukaemia
Possible Vesanoid side effects in 65 year old female
Reported by a physician from Japan on 2012-07-26
Patient: 65 year old female
Reactions: Retinoic Acid Syndrome, Muscle Abscess, Oesophageal Stenosis
Drug(s) suspected as cause:
Vesanoid
Other drugs received by patient: Idamycin
Possible Vesanoid side effects in male
Reported by a physician from Italy on 2012-07-25
Patient: male
Reactions: Hyperhidrosis, Hypercalcaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vesanoid
Possible Vesanoid side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-25
Patient: 49 year old female
Reactions: Pancytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Purinethol
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-15
End date: 2011-12-30
Vesanoid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-16
End date: 2011-12-30
Methotrexate
Start date: 2012-01-28
Purinethol
Start date: 2012-01-28
Methotrexate
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-15
End date: 2011-12-30
Vesanoid
Start date: 2012-02-07
Possible Vesanoid side effects in 41 year old male
Reported by a physician from United States on 2012-07-17
Patient: 41 year old male, weighing 80.1 kg (176.2 pounds)
Reactions: Cardiac Tamponade
Drug(s) suspected as cause:
Vesanoid
Dosage: 40 mg at am and 30 mg at pm
Administration route: Oral
Start date: 2012-01-23
End date: 2012-02-01
Vesanoid
Dosage: 40 mg at am and 30 mg at pm
Administration route: Oral
Start date: 2012-02-05
End date: 2012-02-17
Gemtuzumab Zogamicin
Indication: Acute Promyelocytic Leukaemia
Start date: 2012-01-20
End date: 2012-01-20
Vesanoid
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Start date: 2012-01-13
End date: 2012-01-16
Possible Vesanoid side effects in 41 year old male
Reported by a individual with unspecified qualification from United States on 2012-07-11
Patient: 41 year old male, weighing 80.1 kg (176.2 pounds)
Reactions: Cardiac Tamponade
Drug(s) suspected as cause:
Vesanoid
Indication: Acute Promyelocytic Leukaemia
Start date: 2012-01-30
Gemtuzumab Zogamicin
Indication: Acute Promyelocytic Leukaemia
Start date: 2012-01-20
End date: 2012-01-20
Possible Vesanoid side effects in male
Reported by a physician from Germany on 2012-07-06
Patient: male, weighing 125.0 kg (275.0 pounds)
Reactions: Acute Promyelocytic Leukaemia Differentiation Syndrome, Hepatotoxicity
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Trisenox
Dosage: 17.7 milligram;
Indication: Acute Promyelocytic Leukaemia
Start date: 2012-05-22
End date: 2012-06-06
Vesanoid
Dosage: 120 milligram;
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Start date: 2012-05-22
End date: 2012-06-06
Possible Vesanoid side effects in
Reported by a individual with unspecified qualification from United States on 2012-06-19
Patient:
Reactions: Pulmonary Haemorrhage, Hyperglycaemia, Haematotoxicity
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Indication: Acute Myeloid Leukaemia
Vesanoid
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Cladribine
Indication: Acute Myeloid Leukaemia
Possible Vesanoid side effects in 60 year old male
Reported by a pharmacist from Spain on 2012-06-14
Patient: 60 year old male
Reactions: Haemorrhagic Cerebral Infarction
Adverse event resulted in: death
Drug(s) suspected as cause:
Vesanoid
Other drugs received by patient: Vfend; Konakion; Polaramine; Ondansetron; Omeprazole; Meropenem; Ipratropium Bromide; Actocortina
Possible Vesanoid side effects in 62 year old male
Reported by a individual with unspecified qualification from Spain on 2012-06-13
Patient: 62 year old male
Reactions: Retinoic Acid Syndrome, Acute Respiratory Distress Syndrome, Leukocytosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Vesanoid
Possible Vesanoid side effects in 42 year old female
Reported by a physician from United States on 2012-06-06
Patient: 42 year old female, weighing 89.8 kg (197.6 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Hyperbilirubinaemia, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
Drug(s) suspected as cause:
Posaconazole
Administration route: Oral
Vesanoid
Indication: Acute Myeloid Leukaemia
Start date: 2011-05-11
End date: 2011-05-13
Etoposide
Indication: Acute Myeloid Leukaemia
Start date: 2011-05-06
End date: 2011-05-08
Idarubicin Hydrochloride
Indication: Acute Myeloid Leukaemia
Start date: 2011-05-06
End date: 2011-05-10
Posaconazole
Administration route: Oral
Indication: Antibiotic Therapy
Start date: 2011-05-04
End date: 2011-05-24
Vesanoid
Start date: 2011-05-14
End date: 2011-05-26
Gemtuzumab Zogamicin
Indication: Acute Myeloid Leukaemia
Levofloxacin
Administration route: Oral
Cytarabine
Indication: Acute Myeloid Leukaemia
Start date: 2011-05-06
End date: 2011-05-12
Levofloxacin
Administration route: Oral
Indication: Antibiotic Therapy
Start date: 2011-05-04
End date: 2011-05-13
Possible Vesanoid side effects in female
Reported by a pharmacist from United Kingdom on 2012-05-30
Patient: female
Reactions: Dysphagia
Drug(s) suspected as cause:
Vesanoid
Possible Vesanoid side effects in female
Reported by a pharmacist from Germany on 2012-05-14
Patient: female
Reactions: Drug Interaction, Pulmonary Fibrosis
Drug(s) suspected as cause:
Vesanoid
Other drugs received by patient possibly interacting with the suspect drug: Cytarabine
Indication: Product Used FOR Unknown Indication
Possible Vesanoid side effects in female
Reported by a physician from Japan on 2012-05-03
Patient: female, weighing 43.0 kg (94.6 pounds)
Reactions: Interstitial Lung Disease
Adverse event resulted in: death
Drug(s) suspected as cause:
Vesanoid
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Start date: 2003-01-07
End date: 2003-01-18
Vesanoid
Administration route: Oral
Start date: 2003-01-26
End date: 2003-01-28
Other drugs received by patient: Mercaptopurine; Prednisolone Sodium Succinate; Idarubicin Hydrochloride; Sunrabin; Idarubicin Hydrochloride; Idarubicin Hydrochloride; Idarubicin Hydrochloride
Possible Vesanoid side effects in male
Reported by a physician from Japan on 2012-05-01
Patient: male, weighing 60.0 kg (132.0 pounds)
Reactions: Interstitial Lung Disease
Adverse event resulted in: death
Drug(s) suspected as cause:
Vesanoid
Other drugs received by patient: Idarubicin Hydrochloride; Idarubicin Hydrochloride; Mercaptopurine; Idarubicin Hydrochloride; Idarubicin Hydrochloride; Prednisolone; Enocitabine
Possible Vesanoid side effects in 48 year old male
Reported by a pharmacist from Spain on 2012-04-25
Patient: 48 year old male, weighing 90.0 kg (198.0 pounds)
Reactions: Myositis, Drug Interaction
Drug(s) suspected as cause:
Vesanoid
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Start date: 2011-08-26
End date: 2011-10-07
Heparin Sodium
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-07
End date: 2011-09-30
Other drugs received by patient possibly interacting with the suspect drug: Levofloxacin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-18
End date: 2011-09-28
Furosemide
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-08
End date: 2011-09-26
Urokinase
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-15
End date: 2011-09-15
Omeprazole
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-10-07
Acetaminophen
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-08
Maxipime
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-03
Meropenem
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-05
End date: 2011-09-14
Targocid
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-06
End date: 2011-09-19
Acyclovir Sodium
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-11
End date: 2011-09-13
Noxafil
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-02
End date: 2011-09-17
Polaramine Repetab
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-16
End date: 2011-09-22
Enoxaparin Sodium
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-08-26
Cubicin
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-10
End date: 2011-09-14
Orbenin CAP
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-31
End date: 2011-09-16
Ambisome
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-16
End date: 2011-09-26
Duphalac
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-31
End date: 2011-09-14
Tazobactam
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-14
End date: 2011-09-19
Allopurinol
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-08
Possible Vesanoid side effects in 48 year old male
Reported by a physician from Spain on 2012-04-18
Patient: 48 year old male, weighing 90.0 kg (198.0 pounds)
Reactions: Myositis, Drug Interaction
Drug(s) suspected as cause:
Furosemide
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-08
End date: 2011-09-26
Vesanoid
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Start date: 2011-08-26
End date: 2011-10-07
Meropenem
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-05
End date: 2011-09-14
Acetaminophen
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-08
Enoxaparin Sodium
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-08-26
Dexchlorpheniramine Maleate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-16
End date: 2011-09-22
Omeprazole
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-10-07
Acyclovir
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-11
End date: 2011-09-13
Lactulose
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-31
End date: 2011-09-14
Cefepime
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-03
Noxafil
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-02
End date: 2011-09-17
Urokinase
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-15
End date: 2011-09-15
Tazobactam
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-14
End date: 2011-09-19
Allopurinol
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-08
Cloxacillin Sodium
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-31
End date: 2011-09-16
Levofloxacin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-18
End date: 2011-09-28
Targocid
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-06
End date: 2011-09-19
Cubicin
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-10
End date: 2011-09-14
Amphotericin B
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-16
End date: 2011-09-26
Hibor
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-07
End date: 2011-09-30
Possible Vesanoid side effects in 48 year old male
Reported by a consumer/non-health professional from Spain on 2012-04-18
Patient: 48 year old male, weighing 90.0 kg (198.0 pounds)
Reactions: Myositis
Drug(s) suspected as cause:
Cubicin
Start date: 2011-09-10
End date: 2011-09-14
Heparin
Start date: 2011-09-07
End date: 2011-09-30
Meropenem
Start date: 2011-09-05
End date: 2011-09-14
Allopurinol
Administration route: Oral
Start date: 2011-08-25
End date: 2011-09-08
Duphalac
Dosage: solution
Administration route: Oral
Start date: 2011-08-31
End date: 2011-09-14
Orbenin CAP
Administration route: Oral
Start date: 2011-08-31
End date: 2011-09-16
Targocid
Start date: 2011-09-06
End date: 2011-09-19
Acetaminophen
Start date: 2011-08-25
End date: 2011-09-08
Noxafil
Administration route: Oral
Start date: 2011-09-02
End date: 2011-09-17
Dexchlorpheniramine Maleate
Administration route: Oral
Start date: 2011-09-16
End date: 2011-09-22
Piperacillin and Tazobactam
Start date: 2011-09-14
End date: 2011-09-19
Enoxaparin Sodium
Start date: 2011-08-25
End date: 2011-08-26
Furosemide
Start date: 2011-09-08
End date: 2011-09-26
Urokinase
Dosage: 1df:100 kiu
Start date: 2011-09-15
End date: 2011-09-15
Maxipime
Start date: 2011-08-25
End date: 2011-09-03
Ambisome
Start date: 2011-09-16
End date: 2011-09-26
Levofloxacin
Administration route: Oral
Start date: 2011-09-18
End date: 2011-09-28
Vesanoid
Indication: Acute Promyelocytic Leukaemia
Start date: 2011-08-26
End date: 2011-10-07
Omeprazole
Administration route: Oral
Start date: 2011-08-25
End date: 2011-10-07
Acyclovir
Start date: 2011-09-11
End date: 2011-09-13
Possible Vesanoid side effects in
Reported by a individual with unspecified qualification from United States on 2012-04-16
Patient:
Reactions: Blood Disorder
Drug(s) suspected as cause:
Mercaptopurine
Indication: Acute Promyelocytic Leukaemia
Arsenic Trioxide
Indication: Acute Promyelocytic Leukaemia
Cytarabine
Indication: Acute Promyelocytic Leukaemia
Daunorubicin HCL
Indication: Acute Promyelocytic Leukaemia
Vesanoid
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Methotrexate
Indication: Acute Promyelocytic Leukaemia
Possible Vesanoid side effects in 48 year old male
Reported by a pharmacist from Spain on 2012-04-13
Patient: 48 year old male, weighing 90.0 kg (198.0 pounds)
Reactions: Myositis, Drug Interaction
Drug(s) suspected as cause:
Acyclovir
Dosage: 500 mg;tid;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-11
End date: 2011-09-13
Hibor (Heparin Sodium / 00027704 / )
Dosage: 2500 iu;qd;sc
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-07
End date: 2011-09-30
Abbokinase
Dosage: 100 kiu;qd
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-15
End date: 2011-09-15
Omeprazole
Dosage: 20 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-10-07
Allopurinol
Dosage: 300 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-08
Enoxaparin Sodium
Dosage: 20 mg;qd;sc
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-08-26
Meropenem
Dosage: 1 mg;tid;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-05
End date: 2011-09-14
Levofloxacine (Levofloxacin)
Dosage: 500 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-18
End date: 2011-09-28
Orbenin (Cloxacillin Sodium)
Dosage: 1000 mg;qid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-31
End date: 2011-09-16
Duphalac
Dosage: 10 gm;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-31
End date: 2011-09-14
Targocid
Dosage: 400 mg;qd;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-06
End date: 2011-09-19
Polaramine
Dosage: 12 mg;prn;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-16
End date: 2011-09-22
Ambisome
Dosage: 250 mg;qd;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-16
End date: 2011-09-26
Noxafil
Dosage: po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-02
End date: 2011-09-17
Acetaminophen
Dosage: 1 gm;tid;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-08
Furosemide
Dosage: 20 mg;qd;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-08
End date: 2011-09-26
Cubicin
Dosage: 350 mg;qd;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-10
End date: 2011-09-14
Maxipime
Dosage: 1 gm;tid;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-03
Tazocel (Pip / Tazo)
Dosage: 1 gm;qid;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-14
End date: 2011-09-19
Vesanoid
Dosage: 50 mg;bid;po
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Start date: 2011-08-26
End date: 2011-10-07
Possible Vesanoid side effects in 48 year old male
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-04-09
Patient: 48 year old male, weighing 90.0 kg (198.0 pounds)
Reactions: Myositis
Drug(s) suspected as cause:
Acetaminophen
Dosage: 1 g, tid
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-08
Cubicin
Dosage: 350 mg, uid/qd
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-10
End date: 2011-09-14
Piperacillin and Tazobactam
Dosage: 1 g, qid
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-14
End date: 2011-09-19
Noxafil
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-02
End date: 2011-09-17
Furosemide
Dosage: 20 mg, uid/qd
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-08
End date: 2011-09-26
Targocid
Dosage: 400 mg, uid/qd
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-06
End date: 2011-09-19
Vesanoid
Dosage: 50 mg, bid
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Start date: 2011-08-26
End date: 2011-10-07
Acyclovir
Dosage: 500 mg, tid
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-11
End date: 2011-09-13
Enoxaparin Sodium
Dosage: 20 mg, uid/qd
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-08-26
Maxipime
Dosage: 1 g, tid
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-03
Meropenem
Dosage: 1 g, tid
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-05
End date: 2011-09-14
Levofloxacin
Dosage: 500 mg, uid/qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-18
End date: 2011-09-28
Ambisome
Dosage: 250 mg, uid/qd
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-16
End date: 2011-09-26
Allopurinol
Dosage: 300 mg, uid/qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-08
Omeprazole
Dosage: 20 mg, uid/qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-10-07
Duphalac
Dosage: 10 g, uid/qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-31
End date: 2011-09-14
Heparin Sodium
Dosage: 2500 iu, uid/qd
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-07
End date: 2011-09-30
Polaramine
Dosage: 12 mg, prn
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-16
End date: 2011-09-22
Orbenin CAP
Dosage: 1000 mg, qid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-31
End date: 2011-09-16
Urokinase Asahikasei
Dosage: 100 kiu, total dose
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-15
End date: 2011-09-15
Possible Vesanoid side effects in 48 year old male
Reported by a pharmacist from Spain on 2012-04-06
Patient: 48 year old male, weighing 90.0 kg (198.0 pounds)
Reactions: Myositis
Drug(s) suspected as cause:
Ambisome
Dosage: 250mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-16
End date: 2011-10-26
Orbenin CAP
Dosage: 1000mg four times per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-31
End date: 2011-09-16
Omeprazole
Dosage: 20mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-10-07
Heparin Sodium
Dosage: 2500iu per day
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-07
End date: 2011-09-30
Duphalac
Dosage: 10g per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-31
End date: 2011-09-14
Targocid
Dosage: 400mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-06
End date: 2011-09-19
Vesanoid
Dosage: 50mg twice per day
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Start date: 2011-08-26
End date: 2011-10-07
Meropenem
Dosage: 1g three times per day
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-05
End date: 2011-09-14
Acetaminophen
Dosage: 1g three times per day
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-08
Piperacillin and Tazobactam
Dosage: 1g four times per day
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-14
End date: 2011-09-19
Acyclovir
Dosage: 500mg three times per day
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-11
End date: 2011-09-13
Allopurinol
Dosage: 300mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-08
Furosemide
Dosage: 20mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-08
End date: 2011-09-26
Polaramine
Dosage: 12mg as required
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-16
End date: 2011-09-22
Enoxaparin Sodium
Dosage: 20mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-08-26
Cubicin
Dosage: 350mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-10
End date: 2011-09-14
Noxafil
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-02
End date: 2011-09-17
Maxipime
Dosage: 1g three times per day
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-03
Urokinase
Dosage: 100kiu single dose
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-15
End date: 2011-09-15
Levofloxacin
Dosage: 500mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-18
End date: 2011-09-28
Possible Vesanoid side effects in male
Reported by a pharmacist from Japan on 2012-04-06
Patient: male
Reactions: Pleural Effusion, Pyrexia, Pleural Haemorrhage, Oxygen Saturation Decreased
Drug(s) suspected as cause:
Vesanoid
Dosage: dosage is uncertain.
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Start date: 2012-03-01
End date: 2012-03-02
Vesanoid
Dosage: dosage is uncertain.
Administration route: Oral
Start date: 2012-03-03
End date: 2012-03-03
Possible Vesanoid side effects in 33 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-04
Patient: 33 year old male, weighing 84.0 kg (184.8 pounds)
Reactions: Bronchopulmonary Aspergillosis, Condition Aggravated, Necrotising Ulcerative Gingivostomatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vesanoid
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2010-11-26
End date: 2010-12-15
Imipenem and Cilastatin Sodium
Indication: Product Used FOR Unknown Indication
Start date: 2010-12-02
End date: 2010-12-08
Gentamicin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2010-11-26
End date: 2010-12-16
Ciprofloxacin
Indication: Product Used FOR Unknown Indication
Start date: 2010-12-02
End date: 2010-12-07
Nicorette
Indication: Nicotine Dependence
Start date: 2010-11-27
End date: 2010-12-10
Targocid
Indication: Product Used FOR Unknown Indication
Start date: 2010-12-07
End date: 2010-12-27
Zovirax
Indication: Mouth Ulceration
Start date: 2010-12-02
End date: 2010-12-10
Symbicort
Indication: Product Used FOR Unknown Indication
Start date: 2010-12-02
Noxafil
Indication: Product Used FOR Unknown Indication
Start date: 2010-12-02
End date: 2010-12-06
Clavulanate Potassium
Indication: Product Used FOR Unknown Indication
Start date: 2010-12-07
End date: 2010-12-27
Cytarabine
Indication: Acute Myeloid Leukaemia
Start date: 2010-11-26
End date: 2010-12-02
Spiriva
Indication: Product Used FOR Unknown Indication
Dexamethasone Acetate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2010-11-26
End date: 2010-11-29
Emend
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2010-11-26
End date: 2010-12-06
Colistin Sulfate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2010-11-26
End date: 2010-12-16
Idarubicin HCL
Indication: Acute Myeloid Leukaemia
Start date: 2010-11-26
End date: 2010-11-30
Vfend
Indication: Aspergillosis
Start date: 2010-12-06
End date: 2010-12-18
Vancomycin HCL
Indication: Product Used FOR Unknown Indication
Start date: 2010-12-02
End date: 2010-12-07
Piperacillin and Tazobactam
Indication: Product Used FOR Unknown Indication
Start date: 2010-11-26
End date: 2010-12-01
Other drugs received by patient: Atarax; Nicotinell (Nicotine); Effexor; Atrovent; Morphine; Nicotinell (Nicotine); Nicotine; Factor I (Fibrinogen); Zofran; Idarac; Solian; Oxazepam; Omeprazole; Imodium; Fasturtec; Bricanyl
Possible Vesanoid side effects in 33 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-30
Patient: 33 year old male, weighing 84.0 kg (184.8 pounds)
Reactions: Condition Aggravated, Necrotising Ulcerative Gingivostomatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Piperacillin and Tazobactam
Dosage: 1 df, 4x/day
Start date: 2010-11-26
End date: 2010-12-01
Imipenem and Cilastatin Sodium
Dosage: 1 g, 3x/day
Start date: 2010-12-02
End date: 2010-12-08
Clavulanate Potassium
Dosage: 1 df, 3x/day
Start date: 2010-12-07
End date: 2010-12-27
Zovirax
Dosage: 500 mg, 3x/day
Indication: Mouth Ulceration
Start date: 2010-12-02
End date: 2010-12-10
Symbicort
Dosage: 1 df, 2x/day
Start date: 2010-12-02
Idarubicin HCL
Dosage: 24 mg, alternate day
Indication: Acute Myeloid Leukaemia
Start date: 2010-11-26
End date: 2010-11-30
Nicorette
Dosage: 10 mg, 6x/day
Start date: 2010-11-27
End date: 2010-12-10
Colistin Sulfate
Dosage: 2 df, 3x/day
Administration route: Oral
Start date: 2010-11-26
End date: 2010-12-16
Emend
Dosage: 1 df, 1x/day
Administration route: Oral
Start date: 2010-11-26
End date: 2010-12-06
Vfend
Dosage: 400 mg, 2x/day
Indication: Aspergillosis
Start date: 2010-12-06
End date: 2010-12-18
Vancomycin HCL
Dosage: 1 g, 2x/day
Start date: 2010-12-02
End date: 2010-12-07
Ciprofloxacin
Dosage: 1 df, 2x/day
Start date: 2010-12-02
End date: 2010-12-07
Noxafil
Dosage: 200 mg, 3x/day
Start date: 2010-12-02
End date: 2010-12-06
Dexamethasone Acetate
Dosage: 20 mg, 1x/day
Administration route: Oral
Start date: 2010-11-26
End date: 2010-11-29
Gentamicin
Dosage: 2 df, 3x/day
Administration route: Oral
Start date: 2010-11-26
End date: 2010-12-16
Cytarabine
Dosage: 400 mg/m2
Indication: Acute Myeloid Leukaemia
Start date: 2010-11-26
End date: 2010-12-02
Spiriva
Dosage: 1 df, 1x/day
Targocid
Dosage: 400 mg, 2x/day
Start date: 2010-12-07
End date: 2010-12-27
Vesanoid
Dosage: 90 mg, 1x/day
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2010-11-26
End date: 2010-12-15
Other drugs received by patient: Nicotine; Omeprazole; Nicotine; Atrovent; Bricanyl; Imodium; Effexor; Fasturtec; Idarac; Atarax; Clottafact; Solian; Morphine; Oxazepam; Zofran
Possible Vesanoid side effects in 33 year old male
Reported by a pharmacist from Spain on 2012-03-29
Patient: 33 year old male
Reactions: Blood Lactate Dehydrogenase Increased, Transaminases Increased
Drug(s) suspected as cause:
Vfend
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Antifungal Prophylaxis
Start date: 2012-02-11
End date: 2012-02-14
Vesanoid
Dosage: 90 mg
Administration route: Oral
Indication: Acute Leukaemia
Start date: 2012-02-09
Valtrex
Dosage: 500 mg, 2x/day
Administration route: Oral
Indication: Antiviral Prophylaxis
Start date: 2012-02-11
Other drugs received by patient: Lorazepam; Allopurinol; Targocid
Possible Vesanoid side effects in female
Reported by a physician from France on 2012-03-27
Patient: female
Reactions: Hepatic Failure, Hepatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vesanoid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-27
End date: 2012-01-25
Purinethol
Dosage: 50 mg
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-21
End date: 2012-01-25
Valacyclovir Hydrochloride
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-21
End date: 2012-01-25
Bactrim
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-21
End date: 2012-01-25
Methotrexate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-21
End date: 2012-01-25
Baraclude
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-15
End date: 2012-01-25
Possible Vesanoid side effects in 33 year old male
Reported by a pharmacist from Spain on 2012-03-27
Patient: 33 year old male
Reactions: Blood Lactate Dehydrogenase Increased, Transaminases Increased
Drug(s) suspected as cause:
Valaciclovir
Administration route: Oral
Indication: Antiviral Prophylaxis
Start date: 2012-02-11
Voriconazole
Administration route: Oral
Indication: Antifungal Prophylaxis
Start date: 2012-02-11
End date: 2012-02-14
Vesanoid
Administration route: Oral
Indication: Acute Leukaemia
Start date: 2012-02-09
Other drugs received by patient: Lorazepam; Teicoplanin; Allopurinol
|